This list is an analysis based on recent market events. It's not an investment recommendation.
About
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
The current price of PR80.MU is €0.60 EUR — it has decreased by -7.03% in the past 24 hours. Watch BLS Pharmaceuticals stock price performance more closely on the chart.
What is BLS Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange BLS Pharmaceuticals stocks are traded under the ticker PR80.MU.
What is BLS Pharmaceuticals market cap?▼
Today BLS Pharmaceuticals has the market capitalization of 136.84M
What is BLS Pharmaceuticals revenue for the last year?▼
BLS Pharmaceuticals revenue for the last year amounts to 43.77M EUR.
What is BLS Pharmaceuticals net income for the last year?▼
PR80.MU net income for the last year is 9.05M EUR.
In which sector is BLS Pharmaceuticals located?▼
BLS Pharmaceuticals operates in the Manufacturing sector.
When did BLS Pharmaceuticals complete a stock split?▼
The last stock split for BLS Pharmaceuticals was on June 24, 2026 with a ratio of 1:10.
Where is BLS Pharmaceuticals headquartered?▼
BLS Pharmaceuticals is headquartered in Sydney, Australia.